Lung Cancer Patients May Benefit From Delayed Chemotherapy After Surgery

Aspirin Use Found to Lower Risk of Pancreatic Cancer
January 23, 2017
HCV: Relapse or Reinfection? 
January 24, 2017
Show all

Lung Cancer Patients May Benefit From Delayed Chemotherapy After Surgery

Chemotherapy does not necessarily have to be started immediately after surgery.

A new Yale study suggests that patients with a common form of lung cancer may still benefit from delayed chemotherapy started up to four months after surgery, according to the researchers.

The study was published online by JAMA Oncology on Jan. 5, 2017.

Each year, more people die of lung cancer than of colon, breast, and prostate cancers combined. For patients with non-small-cell lung cancer (NSCLC) — one of two major types of lung cancer — chemotherapy after cancer surgery has been shown to benefit patients with larger tumors or those with cancer in the lymph nodes.

While there is consensus regarding the use of chemotherapy after cancer surgery, the optimal timing is poorly defined. Many clinicians support starting chemotherapy within six to nine weeks after surgery. But factors such as postoperative complications may affect a patient’s ability to tolerate chemotherapy following surgery.

For the study, associate professor of surgery Daniel J. Boffa, M.D., and coauthors used data from patients in the National Cancer Database to examine the relationship between the timing of postoperative chemotherapy and five-year mortality.

Read full article: Lung Cancer Patients May Benefit From Delayed Chemotherapy After Surgery

Read Full Article: Lung Cancer Patients May Benefit From Delayed Chemotherapy After Surgery

The health and medical information on our website is not intended to take the place of advice or treatment from health care professionals. It is also not intended to substitute for the users’ relationships with their own health care/pharmaceutical providers.

Comments are closed.